RARITAN, N.J., July 24, 2018 /PRNewswire/ -- Ortho Clinical Diagnostics today announced that it has received CE mark for Ortho's VITROS® XT 7600 Integrated System. By combining Ortho's proprietary dry ...

QuidelOrtho’s infectious disease test portfolio spans the healthcare continuum from point-of-care settings to high-throughput laboratories and is critical in addressing the growing syphilis epidemic ...

Ortho Clinical Diagnostics announced that it has received CE mark for Ortho's VITROS® XT 7600 Integrated System. By combining Ortho's proprietary dry slide technology with sophisticated digital ...

- Ortho's VITROS® SARS-CoV-2 antigen test can detect SARS-CoV-2 infection in asymptomatic individuals. - The low-cost VITROS antigen test can run up to 130 tests per hour and is a viable choice for ...

There’s a COVID-19 test in your future. And sooner than you might think. NCH Healthcare System has purchased cutting-edge equipment to do mass antibody testing for signs of the coronavirus. According ...

Ortho Clinical Diagnostics has received a CE mark for its new multitest platform that allows laboratories to run two in vitro diagnostic tests simultaneously on one slide. The company’s Vitros XT ...

RARITAN, N.J., Feb. 26, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today ...

RARITAN, N.J. -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced the CE Mark of an enhanced version of its VITROS® NT-proBNP II assay, part of Ortho's expansive cardiac ...

SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...

RARITAN, New Jersey, June 12, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, ...

QuidelOrtho Receives FDA 510(k) Clearance for its VITROS Syphilis Assay SAN DIEGO, August 29, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") has received U.S. Food and ...